'Danazol' Exempt from Duty Under Sl. No. 47A; Tribunal Confirms Validity of CENVAT Credit Reversal for Appellant.

The Tribunal ruled in favor of the appellant, determining that the product 'Danazol' qualifies for the exemption under Sl. No. 47A of Notification No. 4/2006-CE, thus allowing unconditional exemption from duty. The Tribunal also addressed the reversibility of input credit, ruling that the appellant's reversal of CENVAT credit was valid. The department was instructed to verify the accuracy of the credit reversals. The decision highlights the importance of consistent tax assessments and clarifies the classification and exemption eligibility of 'Danazol' under the specified notification.

---

---

Issues involved:
The issues involved in the judgment are whether the product 'Danazol' falls under Sl. No. 47A or Sl. No. 47B of Notification No. 4/2006-CE dated 1.3.2006, and whether the common input credit used in the exempted product is reversible or duty payable as per Rule 6(3) of CENVAT Credit Rules, 2004.

Issue 1 - Product Classification under Notification:
The appellant had been clearing the goods 'Danazol' without duty payment under Sl. No. 47A of Notification No. 4/2006-CE dated 1.3.2006. However, the department contended that 'Danazol' falls under Sl. No. 47B, requiring compliance with specific procedures. Two Show Cause Notices were issued, denying the exemption. The Commissioner (Appeals) upheld the duty demand but set aside the penalties. The appellant argued that 'Danazol' qualifies for the exemption under Sl. No. 47A, citing relevant Tribunal judgments. The respondent argued that 'bulk drugs' fall under Sl. No. 47B, necessitating compliance. The Tribunal referred to previous judgments and ruled in favor of the appellant, granting them unconditional exemption under Sl. No. 47A.

Issue 2 - Reversibility of Input Credit:
Initially, the department denied unconditional exemption to the appellant for 'Danazol' but later conceded eligibility under Sl. No. 47A. However, they required the appellant to reverse the credit or pay a percentage of the sale value of the exempted goods under Rule 6(3) of CENVAT Credit Rules, 2004. The Tribunal noted the department's conflicting positions and ruled in favor of the appellant, allowing the exemption under Sl. No. 47A. The appellant had already reversed the CENVAT credit, and the Tribunal directed the department to verify the accuracy of the reversal claims. The appellant was granted the benefit of Sl. No. 47A, subject to the department's verification of credit reversals.

This judgment clarifies the classification of the product 'Danazol' under Notification No. 4/2006-CE and addresses the issue of reversibility of input credit. The Tribunal's decision provides insights into the interpretation of relevant legal provisions and emphasizes the importance of consistency and accuracy in tax assessments.

---